The building where Grant Wood created his world-famous art soon will become a place where University of Iowa students and faculty can collaborate and innovate to solve problems and change the world.
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy.
Coralville-based IDx uses artificial intelligence technology developed at the University of Iowa to revolutionize the detection of diabetic retinopathy, an eye disease common in people who have diabetes.
The Office of the Vice President for Research and Economic Development (OVPRED) is accepting applications for fall 2018 Arts & Humanities Initiative (AHI) program. This program encourages leading edge scholarship, creative activities and interdisciplinary research.
The next deadline is Tuesday, October 2, 2018.
Visit our website for complete details.